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Abstract
In many tropical areas schistosomiasis is a major health problem causing hepatosplenic, intes-
tinal or urogenital complaints. Hepatosplenic schistosomiasis mansoni is also characterized by
blood coagulation abnormalities. Liver pathology plays a role in the development of haemo-
static changes and the parasitic infection may directly affect coagulation. However, these con-
tributing factors cannot be studied separately in hepatosplenic schistosomiasis infections. This
pilot study provides insight in haemostatic changes in urinary schistosomiasis by studying
coagulation parameters in schistosomiasis haematobium-infected Gabonese schoolchildren.
Selection on urinary schistosomiasis patients without hepatosplenic complaints allows for
the investigation of the direct effects of the parasite on haemostasis. Levels of von
Willebrand Factor (VWF) antigen, active VWF and osteoprotegerin were elevated, indicating
inflammation-mediated endothelial activation. In contrast to hepatosplenic schistosomiasis,
thrombin–antithrombin complex and D-dimer levels were not affected. Despite its small sam-
ple size, this study clearly indicates that Schistosoma haematobium directly alters the activation
status of the endothelium, without initiation of coagulation.
Introduction
The tropical disease schistosomiasis is caused by blood-dwelling parasites of the Schistosoma
genus. The major disease-causing species in humans are Schistosoma mansoni, Schistosoma
haematobium and Schistosoma japonicum (Colley et al., 2014). With almost 800 million people
at risk of infection, schistosomiasis is the second major parasitic disease after malaria
(Steinmann et al., 2006).
The various species of Schistosoma reside in blood vessels at different locations in the body,
and these specific locations determine pathology. Schistosoma mansoni and S. japonicum res-
ide in the mesenteric plexus, and chronic infection results in the development of intestinal or
hepatosplenic schistosomiasis, affecting intestine, liver and spleen (Colley et al., 2014). In con-
trast, S. haematobium resides in the perivesicular plexus. Infection with this species results in
urogenital schistosomiasis, affecting mainly the urogenital tract, although hepatic disease may
occur in severe infections (Cheever et al., 1977; Colley et al., 2014).
In addition to intestinal and hepatic disease, the blood coagulation system is affected in
schistosomiasis mansoni patients (Mebius et al., 2013). These individuals are prone to bleeding
as a result of coagulation-factor deficiencies, and often have reduced platelet counts (reviewed
by Tanabe, 2003). Several factors are presumed to contribute to the loss of coagulation factors
and platelets. First, the consumption of coagulation factors through the continuous activation
of coagulation may be involved, since markers of active coagulation, such as thrombin–antith-
rombin (TAT) complexes, and markers of fibrinolysis, such as D-dimers, are both elevated in
these patients. This activation of coagulation can be induced by the parasite itself, but it is also
assumed that immune responses to schistosomes play a role in the development of haemostatic
abnormalities in hepatosplenic schistosomiasis mansoni – for example, through stimulation of
monocyte-tissue-factor expression (Amer & Amer, 2002). Second, the majority of coagulation
factors are synthesized by the liver. Therefore, impaired liver function, resulting in reduced
hepatic synthesis or clearance of activated coagulation factors, could contribute to the bleeding
phenotype. It remains challenging to unravel the contribution of the parasite and liver damage
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to the development of haemostatic abnormalities in hepatosplenic
schistosomiasis mansoni patients, since these factors cannot be
separated in hepatosplenic disease.
This pilot study aims to elucidate the contribution of the
parasite to the development of coagulation abnormalities in
Schistosoma infections by studying haemostatic parameters in
schoolchildren infected with S. haematobium. Since S. haemato-
bium infections primarily cause urogenital schistosomiasis, strict
selection on S. haematobium-infected individuals without hepa-
tosplenomegaly limits the influence of impaired hepatic function
and allows investigation of the effect of only the parasitic infection
on the development of coagulation abnormalities.
Materials and methods
Participants and sample collection
Ten schoolchildren with non-hepatosplenic schistosomiaisis haema-
tobium and four healthy controls without S. haematobium infection
were recruited at the Centre de Recherches Médicales de Lambaréné
(CERMEL), Lambaréné, Gabon. The study was approved by
the CERMEL Institutional Ethics Committee (CEI, CEI-MRU 002
26/1/2016). Participants were schoolchildren without hepatosplenic
complaints from Zilé-PK15 areas – S. haematobium-endemic areas
surrounding Lambaréné (Ateba Ngoa et al., 2014). The presence of
possible asymptomatic other infectious diseases that could affect
haemostasis, such as malaria, were not investigated, but if present
among the included participants these asymptomatic infections
are expected to be evenly distributed between participants with
and without urinary schistosomiasis. Informed consent was
obtained from the parents or legal guardians of all children, and
all infected individuals received treatment with praziquantel after
sample collection. Venous blood was collected in a tube containing
1:10 volume of anticoagulant 3.2% sodium citrate solution. Whole
blood was analysed with the Pentra 60 analyser (Horiba, Kyoto,
Japan). Citrated platelet-poor plasma was obtained by twofold cen-
trifugation of citrated blood at 2000×g for 15 min. Citrated plasma
was aliquoted and stored at −80°C.
Determination of S. haematobium infection
Circulating anodic antigen (CAA) levels were determined in 20 µl
citrated plasma with the wet reagent SCAA20 (standard serum/
plasma CAA test on 20 µl trichloroacetic acid (TCA) extract) lat-
eral flow assay, as described by Corstjens et al. (2014). Samples
were treated with 4% TCA to remove interfering components.
CAA levels were calculated with a four-parametric curve-fitting
method, using a standard dilution curve of the TCA-soluble frac-
tion of schistosome adult worm antigen (AWA-TCA), which con-
tains approximately 3% (w/w) CAA. The lower detection limit of
the SCAA20 was 150 pg/ml AWA-TCA (=5 pg CAA/ml).
Participants were considered positive when CAA levels were
above 5 pg/ml. In addition, for all participants a midstream
urine sample was collected during the daytime and at least
10 ml urine was passed through a 12.0 µm polyamide N-filter
(Millipore, Billerica, MA, USA). Schistosoma haematobium eggs
were detected by microscopic examination.
Enzyme-linked immunosorbent assay
Levels of D-dimer were measured in plasma with the Technozym
D-dimer ELISA kit (Stago BNL, Leiden, The Netherlands)
according to the manufacturer’s instructions. Levels of von
Willebrand Factor (VWF) antigen (VWF:ag), active VWF,
ADAMTS-13 antigen (ADAMTS-13:ag), osteoprotegerin (OPG)
and TAT complexes were measured in plasma with ELISA.
Ninety-six-well or 384-well white Maxisorp microtiter plates
(Thermo Scientific, Roskilde, Denmark) were coated overnight
at 4°C with polyclonal rabbit-anti-human VWF (0.775 µg/ml;
A0082; DAKO, Carpinteria, CA, USA), AU/VWFa-11 nanobody
(Hulstein et al., 2005) (1.98 µg/ml), D053 (0.5 µg/ml; Sanquin,
Amsterdam, The Netherlands), mouse-anti-human OPG/
TNFRSF11B (1 µg/ml; R&D Systems, Minneapolis, MN, USA)
or sheep-anti-human Thrombin (1 µg/ml; Stago BNL, Leiden,
The Netherlands) in coating buffer (40 mM sodium carbonate,
35 mM sodium bicarbonate, 3 mM sodium azide, pH 9.6). Plates
were washed four times with washing buffer (phosphate-buffered
saline (PBS; ThermoFisher Scientific, Waltham, MA, USA), 0.05%
Tween20, pH 7.4) between all incubation steps, and blocked for
one hour at room temperature with blocking buffer (PBS, 1%
bovine serum albumin (BSA), pH 7.4). Citrated plasma and stan-
dards were diluted in blocking buffer: 125-fold for VWF:ag
ELISA, five- and tenfold for active VWF ELISA, 40-fold for
ADAMTS-13:ag ELISA and fourfold for OPG and TAT ELISAs,
and incubated for one hour at room temperature. Used standards
were serial dilutions of normal pooled plasma (Sanquin,
Amsterdam, The Netherlands) with a known concentration of
VWF:ag for VWF:ag and ADAMTS-13:ag, normal pooled serum
with known concentrations of TAT and OPG for TAT and
OPG ELISAs and VWF-depleted plasma (Affinity Biologicals,
Ancaster, Canada) supplemented with recombinant R1341Q-
VWF for active VWF ELISA. Following sample incubation, the
plates were incubated at room temperature for one hour with the
following detection and secondary antibodies diluted in blocking
buffer: peroxidase-conjugated rabbit-anti-human VWF (0.325 µg/
ml), peroxidase-conjugated rabbit-anti-human VWF (1.2 µg/ml),
biotinylated polyclonal sheep-anti-human ADAMTS-13 (0.25 µg/
ml; R&D Systems, Minneapolis, MN, USA) and streptavidin-
mono-horseradish peroxidase (HRP) (0.83 µg/ml; DAKO,
Carpinteria, CA, USA), biotinylated goat-anti-human OPG/
TNFRSF11B (100 ng/ml; R&D Systems, Minneapolis, MN, USA)
and streptavidin-mono-HRP (0.25 µg/ml), and peroxidase-
conjugated sheep-anti-human antithrombin (0.5 µg/ml; Stago
BNL, Leiden, The Netherlands). ELISAs were developed with
SuperSignal West Pico Chemiluminescent Substrate
(ThermoFisher Scientific, Waltham, MA, USA) and luminescence
was detected with the Synergy2 ELISA reader (BioTek, Winooski,
VT, USA). Antigen concentrations were calculated with a five-
parametric curve-fitting method, using a dilution curve of the
standard. The lower detection limits of the ELISAs were: 6.8 ng/ml
(VWF:ag), 16 ng/ml (active VWF), 1.6% (ADAMTS-13:ag),
10.6 pg/ml (OPG) and 2.8 pM (TAT).
Ristocetin co-factor activity assay
Citrated plasma was diluted sevenfold in imidazole buffer
(100 mM imidazole, 100 mM NaCl, pH 7.4). A standard dilution
curve was prepared of diluted normal pooled plasma. Then,
200 µl BC von Willebrand Reagent (Siemens Healthcare,
Erlangen, Germany) was added to the 70 µl sample in a 96-well
clear Maxisorp microtiter plate. Following 10 min incubation at
37°C and 20 min incubation at room temperature, to allow plate-
let aggregates to precipitate, 100 µl of the mixture was transferred
to a new plate and non-aggregated platelets were measured at
2 M.M. Mebius et al.
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350 nm. Ristocetin co-factor activity (VWF:RCo) was calculated
with a five-parametric curve-fitting method, using a dilution
curve of the standard. The lower detection limit of the assay
was 3% VWF:RCo.
ADAMTS-13 activity measurement
ADAMTS-13 activity was measured in a kinetic assay using the
fluorescence resonance energy transfer substrate VWF73
(FRETS-VWF73; Peptide Institute, Osaka, Japan) as previously
described (Kokame et al., 2005). Samples were tenfold diluted
in Tris buffer (5 mM Tris, 25 mM calcium chloride, 0.005%
Tween20, pH 6.0). FRETS-VWF73 was added to a final concen-
tration of 2 µM and fluorescence (λex 340 nm, λem 450 nm) was
measured in a 96-well black microtiter plate (Thermo Scientific,
Roskilde, Denmark) every 30 s for one hour at 30°C with a
Spectramax M2e device (Molecular Devices, Sunnyvale, CA,
USA).
Statistical analysis
Analyses were done using PRISM software (GraphPad, San Diego,
CA, USA, version 6.01). Infected and non-infected control groups
were compared using the Mann–Whitney U-test and P≤ 0.05 was
considered statistically significant.
Results and discussion
We included ten schoolchildren with schistosomiasis haemato-
bium and four healthy children from S. haematobium-endemic,
Table 1. Participant characteristics.
Schistosoma haematobium-infected children Controls
Number, n 10 4
Age (y), mean (SD) 11 (3) 8 (1)
Male, n (%) 5/10 (50) 3/4 (75)
Weight (kg), mean (SD) 37 (13) 27 (2)
Height (m), mean (SD) 1.47 (0.16) 1.34 (0.03)
CAA (pg/ml), mean (SD) 2166 (3062) 0 (0)
Egg count positive, n (%) 9/10 (90) 0/4 (0)
Egg count/10 ml urine, mean (SD) 272 (289) 0 (0)
Parasitic co-infections, n (%)
Ascaris 0/8 (0) 0/3 (0)
Ancylostoma 0/8 (0) 0/3 (0)
Trichuris 3/8 (38) 1/3 (33)
Missing 2 1
Whole blood analysis, mean (SD)
Haemoglobin (g/dl) 11.0 (1.9) 11.7 (1.3)
Missing 1 0
Platelets (n × 109/l) 253 (66) 322 (54)
Missing 1 0
White blood cells (n × 109/l) 10.5 (3.5) 10.1 (2.9)
Missing 1 0
Eosinophils (n × 109/l) 1.8 (0.8) 1.9 (1.3)
Missing 5 1
Lymphocytes (n × 109/l) 4.2 (0.9) 3.6 (0.5)
Missing 1 0
Monocytes (n × 109/l) 0.7 (0.2) 0.9 (0.2)
Missing 1 0
Splenomegaly, n (%) 1/9 (11) 0/4 (0)
Missing 1 0
Hepatomegaly, n (%) 0/9 (0) 0/4 (0)
Missing 1 0
Data are number with percentage or mean with SD. CAA, circulating anodic antigen; SD, standard deviation.
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rural areas surrounding Lambaréné (Gabon) (table 1). Infection
status was based on CAA levels in plasma (Corstjens et al.,
2014) combined with the detection of viable eggs in urine, since
the detection of eggs in urine as the only method to confirm
infection has a low sensitivity (Colley et al., 2014). As expected,
a positive correlation was found between the number of eggs
detected by urine filtration and the concentration of CAA in
plasma (not shown). Hepatomegaly was absent in all studied indi-
viduals and splenomegaly was absent in nine out of ten infected
and in all non-infected individuals; therefore, all infected children
were characterized as strictly urogenital schistosomiasis
haematobium.
In hepatosplenic schistosomiasis mansoni, levels of VWF:ag
are highly elevated and inversely correlate with platelet counts,
as patients experience thrombocytopenia (Correia et al., 2009).
To determine the effect of Schistosoma infection on VWF levels
in urinary schistosomiasis, we determined VWF:ag, active VWF
and VWF ristocetin cofactor activity (VWF:RCo) in our study
participants. VWF is secreted by endothelial cells and circulates
in a globular conformation in which the platelet-binding
A1-domain is inaccessible (Hulstein et al., 2005). Under blood
flow, VWF unfolds and adopts an active platelet-binding con-
formation (active VWF) that can be detected using the AU/
VWFa-11 nanobody (Hulstein et al., 2005). Besides flow,
ristocetin can also be used to unfold VWF and study its binding
to platelets (VWF:RCo). Levels of VWF:ag and active VWF were
significantly increased in infected children compared to non-
infected controls (P = 0.002 and P = 0.004, respectively; see
fig. 1a, b). The elevated VWF:ag levels indicate either increased
secretion or reduced breakdown of VWF. The proportion of
VWF that is active (percentage of active VWF) is slightly
decreased in infected children compared to non-infected indivi-
duals, indicating that increased conformational activation of cir-
culating VWF is not responsible for the observed increase in
active VWF (P = 0.024; fig. 1c). In contrast to increased VWF:
ag and active VWF levels, VWF:RCo was low or absent in all indi-
viduals (P = 0.6234; fig. 1d). As all individuals had normal platelet
counts ((253 ± 66) × 109/l and (322 ± 54) × 109/l in infected and
non-infected individuals, respectively (P = 0.1063)) and plasma
from Dutch controls showed normal VWF:RCo activity (data
not shown), this observation cannot be explained by low platelet
counts or poor performance of the VWF:RCo assay. Reduced or
absent platelet aggregation on ristocetin in Africans compared
to Europeans has been reported previously (Dupuy et al., 1978;
Buchanan et al., 1981). Reduced platelet function was attributed
to a plasma inhibitor of ristocetin-induced platelet aggregation
(Dupuy et al., 1978; Buchanan et al., 1981), though genetic poly-
morphisms in VWF could also affect the ristocetin-based activity
Fig. 1. Haemostatic parameters in Schistosoma haematobium-infected schoolchildren. VWF:ag levels (a), active VWF levels (b), ADAMTS-13:ag levels (e), OPG levels
(g), TAT levels (h) and D-dimer levels (i) were measured with ELISA in citrated plasma of S. haematobium-infected schoolchildren and non-infected controls.
Percentage of active VWF (c) was calculated with the determined active VWF and VWF:ag levels. VWF:RCo (d) was determined with the BC von Willebrand
Reagent. ADAMTS-13 activity (f) was determined with the FRETS-VWF73 assay. Dotted lines indicate normal ranges (a, d) or cut-off values (g–i). Statistical analysis
was performed with a Mann–Whitney U-test. P ≤ 0.05 was considered statistically significant. Abbreviation: ns, not significant.
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assay (Flood et al., 2010). It is, however, unclear whether these
accounted for the observed low VWF:RCo activity in our study.
In summary, in urinary schistosomiasis haematobium, VWF:ag
and active VWF levels are elevated and do not correlate with
platelet counts as thrombocytopenia is absent.
Changes in levels of VWF:ag and active VWF could reflect
defects in the VWF-degrading protease ADAMTS-13 (Hulstein
et al., 2005), but could also indicate endothelial activation (Lip
& Blann, 1997). To study the functionality of ADAMTS-13,
both ADAMTS-13:ag levels and ADAMTS-13 activity were deter-
mined. ADAMTS-13:ag levels and ADAMTS-13 activity were
normal in both infected and non-infected children (P = 0.4116
and P = 0.5774, respectively; see fig. 1e, f), so no defects in
VWF-degradation are present.
Next, endothelial activation was determined using OPG levels
as a marker for inflammation-mediated endothelial activation
(Zannettino et al., 2005). OPG is not directly involved in coagu-
lation, as OPG is a cytokine of the TNF receptor superfamily
involved in several physiological processes, among which are
angiogenesis, osteogenesis and inflammation. Elevated levels of
OPG were observed in the S. haematobium-infected children ver-
sus non-infected controls (P = 0.036; fig. 1g, dotted line indicates
cut-off value). Simultaneous elevation of both VWF:ag and OPG
during schistosomiasis haematobium indicates inflammation-
mediated endothelial activation and is in line with the reported
co-localization of these markers in endothelial Weibel Palade
bodies and their simultaneous secretion upon endothelial cell
stimulation (Zannettino et al., 2005).
Several mechanisms may explain activation of the vessel wall.
Secretion of OPG is stimulated by the inflammatory cytokines
TNF-α and IL-1β (Zannettino et al., 2005). In hepatosplenic
schistosomiasis mansoni patients, TNF-α production by periph-
eral blood mononuclear cells (PBMC) is elevated and plasma
levels of soluble TNF receptor I and II are increased (Mwatha
et al., 1998), suggesting the contribution of inflammatory cyto-
kines produced during infection to the observed increased OPG
levels. However, no correlation between serum levels of TNF-α
and infection status or disease severity is observed in schistosom-
iasis haematobium (Bustinduy et al., 2015). Passage of schisto-
some eggs through the vessel wall or egg-derived materials
could also induce endothelial activation (File, 1995). Furthermore,
endothelial adhesion of adult S. mansoni through their ventral
sucker could damage the endothelium (Silva et al., 1998) and the
presence of the adult worm pair in the small veins could alter
blood flow, leading to endothelial activation (Mebius et al., 2013).
The observation that endothelial activation occurs during
urinary schistosomiasis is of importance, as elevated levels of
VWF, OPG and endothelial activation are associated with throm-
bosis and cardiovascular disease (Jono et al., 2002; Conway et al.,
2003). Ongoing coagulation has been demonstrated in hepatos-
plenic schistosomiasis mansoni, reflected by increased levels of
TAT and D-dimer (Tanabe, 2003). Therefore, we investigated
whether the observed endothelial activation in urinary schisto-
somiasis haematobium results in a procoagulant phenotype in
urinary schistosomiasis. In contrast to hepatosplenic schistosom-
iasis mansoni patients, TAT and D-dimer levels were generally
low in our study population and we could not demonstrate
differences in urinary schistosomiasis patients compared to the
non-infected individuals (P = 0.4116 and P = 0.7524, respectively;
fig. 2h, i, dotted line indicates cut-off value), indicating that there
is no ongoing coagulation or fibrinolysis in these individuals.
However, five of the infected children had TAT levels above the
normal threshold, without elevated D-dimer levels. Coagulation
activation may have occurred in these individuals leading to low-
level thrombin activation, followed by subsequent inhibition of
the formed thrombin by antithrombin, leading to the formation
of TAT without fibrin formation, which explains the absence of
D-dimers in these individuals.
Here, we report the first study on the direct effects of S. hae-
matobium on haemostatic abnormalities in urinary schistosomia-
sis haematobium patients without hepatosplenic complaints.
Despite the small sample size of this pilot study, our observations
indicate that S. haematobium directly alters the activation status of
the vessel wall. This is not unexpected as the relatively large size of
the adult worm pairs in the blood vessel will provoke substantial
turbulence and increased shear stress along the vessel wall – pro-
cesses known to induce endothelial activation (Mebius et al.,
2013). In contrast to reports on coagulation abnormalities in
hepatosplenic schistosomiasis mansoni, ongoing coagulation
and fibrinolysis, which is reflected by elevated levels of TAT
and D-dimer, was absent in urinary schistosomiasis patients
that thus lack apparent physiological changes in their haemosta-
sis. In schistosomiasis mansoni, the reported coagulopathy may
be aggravated as a result of impaired liver function (Tanabe,
2003). The direct effects of the parasite on the vessel wall are
also of interest, as endothelial activation and elevated levels of
VWF are linked to thrombosis. Therefore, we hypothesize that dir-
ect activation of the endothelium by S. haematobium may be
involved in the initiation of coagulation abnormalities in schisto-
somiasis. Interestingly, a VWF-cleaving peptidase was recently dis-
covered in S. mansoni, which suggests that schistosomes have
strategies to counteract endothelial activation and elevated levels
of VWF, which are unfavourable for both the parasite and its
host, as this can lead to thrombosis (Mebius et al., manuscript in
preparation). Larger studies on endothelial activation in schisto-
somiasis haematobium patients with various disease severities are
required to confirm our observations, and to elucidate the mechan-
isms involved in schistosomal-induced endothelial activation and
the consequences of this endothelial activation on haemostasis.
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